Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Shares Outstanding (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Shares Outstanding for 17 consecutive years, with $92.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 0.74% to $92.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $92.3 million through Dec 2025, up 0.74% year-over-year, with the annual reading at $92.3 million for FY2025, 0.74% up from the prior year.
  • Shares Outstanding hit $92.3 million in Q4 2025 for Integra Lifesciences Holdings, roughly flat from $92.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $92.3 million in Q2 2025 to a low of $89.4 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $90.9 million across 5 years, with a median of $90.9 million in 2023.
  • Biggest five-year swings in Shares Outstanding: grew 0.32% in 2021 and later grew 0.98% in 2022.
  • Year by year, Shares Outstanding stood at $89.6 million in 2021, then rose by 0.98% to $90.5 million in 2022, then increased by 0.49% to $90.9 million in 2023, then rose by 0.76% to $91.6 million in 2024, then rose by 0.74% to $92.3 million in 2025.
  • Business Quant data shows Shares Outstanding for IART at $92.3 million in Q4 2025, $92.3 million in Q3 2025, and $92.3 million in Q2 2025.